Adverse Event Following Immunization with COVID-19 Vaccine Case Report Form – Complete this report on a person who has received COVID-19 vaccine and experiences an event that required medical attention, was unusual or unexpected, was serious, and was suspected to be related to the vaccine. – BCCDC
Registration for vaccinations is now through the Provincial Booking System. Patients should be reminded to ensure they are registered. This includes seniors, Indigenous people and people who are clinically extremely vulnerable who booked dose 1 through their health authority before April 6. The public can ensure they are registered on the Get Vaccinated page.
Doctors to Register through Provincial System for Vaccine Second Dose – [login required] – VCH reminds physicians to register through the provincial online booking system, GetVaccinated, to receive your second dose of COVID-19 vaccine. Your first dose was recorded in the system, and now you must be attached to your registration profile. If you have registered already, there is no need to do so again. Doctors of BC provides a registration reminder here.
Interchangeability of Authorized COVID-19 Vaccines – guidelines have changed to allow for mixing and matching COVID-19 vaccines- National Advisory Committee on Immunization (NACI).
B.C.’s COVID-19 Vaccine Registration and Schedule – Everyone in B.C. who is 12+ years (born 2009) should register to get vaccinated through the Get Vaccinated provincial registration system once. This includes seniors, Indigenous people, and people who are clinically extremely vulnerable who booked dose 1 through their health authority before April 6, and people who received dose 1 of AstraZeneca at a local pharmacy.
Appointment booking invitations for first dose vaccinations are currently being sent to people born 2003 or earlier (18+), and people 16+ who are pregnant or clinically extremely vulnerable. Everyone will get dose 2within 16 weeks of their first vaccination appointment.
Priority Vaccination for Pregnant People – All pregnant people who are age 16+ are now eligible to receive the COVID-19 vaccine as a priority population through B.C.’s Immunization Plan. Read the announcement here.
Health Canada Authorizes Pfizer Vaccine for Children 12 to 15 Year of Age – Pfizer-BioNTech’s COVID-19 vaccine is the first COVID-19 vaccine authorized in Canada for use in children. The vaccine was initially authorized for people 16+ years on December 9, 2020.
All viruses mutate over time and it is expected that the COVID-19 virus will evolve and change. Some changes result in variants of concern, which cause the virus to act differently in ways that are significant to public health.
B.1617 WHO Designates B.1617 as a Variant of Concern – WHO’s weekly epidemiological update includes a special focus on COVID-19 variants (Page 4).
Variant of Concern Dashboard – PHAC provides daily count of cases across Canada
COVID-19 Variants Information – BCCDC online resource
VoC Testing and Severity by VoC and Age – Ministry of Health Presentation
COVID-19 Variants of Concern – IPAC provides overview and shares Canadian and International guidelines, policies and standards
“Health care providers play a crucial role in communicating facts about vaccine safety to their clients. Like all other medical interventions, vaccines have risks. These risks must be carefully weighed against the risk of disease. The following resources can assist health care providers in addressing client’s concerns regarding vaccine safety.” – BCCDC, Vaccine Safety
* Projects to Encourage Vaccine Uptake in Canada – Five new projects receiving funding through the Immunization Partnership Fund (IPF) to support vaccination efforts across Canada. – Public Health Agency of Canada
* Vaccine Community Innovation Challenge to Help Promote Vaccine Confidence – 20 finalists announced under the Challenge, who will receive a $25,000 grant to develop and launch their projects to increase people’s confidence in COVID-19 vaccines and reinforce public health measures in their communities. – Public Health Agency of Canada
* Vaccine Confidence Info Sheets and Q&A – Vancouver Coastal Health
* DocTalks Podcast: Vaccine Hesitancy – Talking to patients about the COVID-19 vaccine – Doctors of BC
* Engage Vaccine Hesitant Patients – UBC Immunization Toolkit
* Vaccine Hesitancy Resources – Immunize Canada
* Guide to Responding to Vaccine Hesitancy – Doctors Manitoba
* The ASK Approach for effective immunization communication (Quick Reference Card) – BCCDC Resource for Health Professionals
* COVID-19 Vaccination Toolkit – BCCDC guidance for health professionals
* Vaccine Office Toolkit – Doctors of BC
* Multi-Lingual COVID-19 Vaccine FAQ – Resource available in 13 languages – HealthLinkBC
* Monitoring Vaccine Uptake, Safety and Effectiveness – BCCDC patient resource, with specific information on the AstraZeneca and COVISHIELD vaccines.
* Clinical Care Guidance on Vaccine-induced Immune Thrombotic Thrombocytopenia – BC COVID-19 Therapeutics
* How the COVID-19 Vaccines Work and What they Protect Against – Doctors of BC patient resource
2nd Dose Choice for Patients who Received AstraZeneca/COVISHIELD – Considerations for patients when choosing which vaccine to get for a 2nd dose. – BCCDC
AstraZeneca / COVISHIELD First Dose COVID-19 Immunization Q&A – NACI recommends that people who received AstraZeneca vaccine as a first dose may be offered either AstraZeneca or an mRNA vaccine as a second dose. This Q&A is intended for health care professionals.
Expiry Date for AstraZeneca Lots Extended by One Month – Health Canada
B.C. Approves AstraZeneca for People 30+ – As of April 27, B.C. will expand the use of AstraZeneca vaccine to people 30+ in specific high-transmission communities and through pharmacies with supply.
Summary Safety Review – AstraZeneca COVID-19 Vaccine – Health Canada concluded that a link between AstraZeneca and the risk of blood clots is possible but very rare, and the overall benefits of the vaccine in protecting from COVID-19 continue to outweigh its risks.
Statement on the use of AstraZeneca COVID-19 Vaccine – Canada’s National Advisory Committee on Immunization has updated its Recommendations on the Use of COVID-19 Vaccines to expand the use of the AstraZeneca vaccine to people over the age of 30, as outlined on page 34.
Changes to the use of AstraZeneca and COVISHIELD Vaccines – BCCDC patient FAQ
Updates to Immunization Manual – Information was revised on May 7, 2021 to reflect updates including: the authorized age for Pfizer to 12 years+, pregnant or breastfeeding patient vaccination and use of ibuprofen, rare cases of serious blood clots, and notification of 2nd dose.
Pfizer-BioNTech COVID-19 Vaccine – What you need to know
Moderna COVID-19 Vaccine – What you need to know
AstraZeneca COVID-19 Vaccine – What you need to know
Janssen COVID-19 Vaccine – What you need to know
COVID-19 mRNA Vaccines – HealthLinkBC COVID-19 vaccination webpage
Vaccines for COVID-19 – Health Canada provides information about each authorized vaccine, how it works, how it is given, ingredients, allergies, possible side effects and safety monitoring.
* Authorized vaccines – Pfizer | Moderna | AstraZeneca | Janssen
* Types of vaccines – mRNA vaccines | Viral vector-based vaccines